UB Paderborn / Katalog / Suche / in CDI

26 – 50 von 597

Sortiert nach

Lipoprotein-associated phospholipase A(2) and future risk of subclinical disease and cardiovascular events in individuals with type 2 diabetes: the Cardiovascular Health Study

Diabetologia, 2011-02, Vol.54 (2), p.329

2011

Volltextzugriff (PDF)

Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis

Canadian Medical Association journal, 2009-01, Vol.180 (1), p.32

2009

Volltextzugriff (PDF)

Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials

JAMA : the journal of the American Medical Association, 1993-10, Vol.270 (13), p.1589

1993

Volltextzugriff (PDF)

Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project

European heart journal, 2002-02, Vol.23 (3), p.207-215

2002

Volltextzugriff (PDF)

Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials

BMJ (British Medical Journal), 2011-06, Vol.342 (7811), p.d3215-1348

International edition, 2011

Volltextzugriff (PDF)

Reduction in cardiovascular events during pravastatin therapy : pooled analysis of clinical events of the pravastatin atherosclerosis intervention program

Circulation (New York, N.Y.), 1995-11, Vol.92 (9), p.2419-2425

1995

Volltextzugriff (PDF)

Are drugs within a class interchangeable?

The Lancet (British edition), 1999-10, Vol.354 (9185), p.1202-1204

1999

Volltextzugriff (PDF)

Lipoprotein-associated phospholipase A2 and future risk of subclinical disease and cardiovascular events in individuals with type 2 diabetes: the Cardiovascular Health Study

Diabetologia, 2011-02, Vol.54 (2), p.329-333

2011

Volltextzugriff (PDF)

Cholesterol reduction yields clinical benefit : a new look at old data

Circulation (New York, N.Y.), 1995-04, Vol.91 (8), p.2274-2282

1995

Volltextzugriff (PDF)

Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials

The Lancet (British edition), 2019-02, Vol.393 (10170), p.407-415

2019

Volltextzugriff (PDF)

Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease

Journal of the American College of Cardiology, 2001-09, Vol.38 (3), p.705-711

2001

Volltextzugriff (PDF)

Differences in medical care and disease outcomes among black and white women with heart disease

Circulation (New York, N.Y.), 2003-09, Vol.108 (9), p.1089-1094

2003

Volltextzugriff (PDF)

A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers

Canadian Medical Association journal (CMAJ), 2009-05, Vol.180 (10), p.E47

2009

Volltextzugriff (PDF)

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials

The Lancet (British edition), 2015-04, Vol.385 (9976), p.1397-1405

2015

Volltextzugriff (PDF)

Use of calcium channel blockers and breast carcinoma risk in postmenopausal women

Cancer, 1997-10, Vol.80 (8), p.1438-1447

1997

Volltextzugriff (PDF)

Oral anticoagulation in patients with atrial fibrillation: adherence with guidelines in an elderly cohort

The American journal of medicine, 1999-02, Vol.106 (2), p.165-171

1999

Volltextzugriff (PDF)

Time to act on drug safety

JAMA : the journal of the American Medical Association, 1998-05, Vol.279 (19), p.1571

1998

Volltextzugriff (PDF)

HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data

Atherosclerosis, 1998-05, Vol.138 (1), p.11-24

1998

Volltextzugriff (PDF)

Use of nonsteroidal antiinflammatory drugs : An update for clinicians a scientific statement from the american heart association

Circulation (New York, N.Y.), 2007-03, Vol.115 (12), p.1634-1642

2007

Volltextzugriff (PDF)

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

The Lancet (British edition), 2012-08, Vol.380 (9841), p.581-590

2012

Volltextzugriff (PDF)

Are all angiotensin-converting enzyme inhibitors interchangeable?

Journal of the American College of Cardiology, 2001-04, Vol.37 (5), p.1456-1460

2001

Volltextzugriff (PDF)

The risk of myocardial infarction associated with antihypertensive drug therapies

JAMA : the journal of the American Medical Association, 1995-08, Vol.274 (8), p.620

1995

Volltextzugriff (PDF)

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

The Lancet (British edition), 2010-11, Vol.376 (9753), p.1670-1681

2010

Volltextzugriff (PDF)

Clinical Implications of Recent Findings from the Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial (ALLHAT) and Other Studies of Hypertension

Annals of internal medicine, 2001-12, Vol.135 (12), p.1074

2001

Volltextzugriff (PDF)

Parecoxib, valdecoxib, and cardiovascular risk

Circulation (New York, N.Y.), 2005-01, Vol.111 (3), p.249-249

2005

Volltextzugriff (PDF)

26 – 50 von 597

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(551)
Mit Volltextzugriff
(464)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(451)
Science & Technology
(430)
Life Sciences & Biomedicine
(422)
Female
(241)
Male
(230)
Biological And Medical Sciences
(225)
Medical Sciences
(223)
Aged
(201)
Cardiovascular System & Cardiology
(167)
Middle Aged
(149)
Risk Factors
(128)
Cardiac & Cardiovascular Systems
(123)
General & Internal Medicine
(112)
Medicine, General & Internal
(110)
Pharmacology. Drug Treatments
(98)
Peripheral Vascular Disease
(96)
Adult
(92)
Hypertension - Drug Therapy
(78)
Clinical Trials As Topic
(74)
Cardiology. Vascular System
(69)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Lipoprotein-associated phospholipase A(2) and future risk of subclinical disease and cardiovascular events in individuals with type 2 diabetes: the Cardiovascular Health Study

Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis

Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials

Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project

Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials

Reduction in cardiovascular events during pravastatin therapy : pooled analysis of clinical events of the pravastatin atherosclerosis intervention program

Are drugs within a class interchangeable?

Lipoprotein-associated phospholipase A2 and future risk of subclinical disease and cardiovascular events in individuals with type 2 diabetes: the Cardiovascular Health Study

Cholesterol reduction yields clinical benefit : a new look at old data

Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials

Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease

Differences in medical care and disease outcomes among black and white women with heart disease

A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials

Use of calcium channel blockers and breast carcinoma risk in postmenopausal women

Oral anticoagulation in patients with atrial fibrillation: adherence with guidelines in an elderly cohort

Time to act on drug safety

HMG-CoA reductase inhibitor therapy and stroke risk reduction: an analysis of clinical trials data

Use of nonsteroidal antiinflammatory drugs : An update for clinicians a scientific statement from the american heart association

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

Are all angiotensin-converting enzyme inhibitors interchangeable?

The risk of myocardial infarction associated with antihypertensive drug therapies

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

Clinical Implications of Recent Findings from the Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial (ALLHAT) and Other Studies of Hypertension

Parecoxib, valdecoxib, and cardiovascular risk

Suchergebnisse filtern